Roche is letting 6 percent of its workforce, or about 4,800 people, go, reports Ed Silverman at Pharmalot. A Roche statement on its Operational Excellence Program says that 800 cuts will be to product development staff and 600 cuts to research and early development positions, while sales and marketing will bear the largest share of the cuts, with a loss of 2,650 positions. In addition, there will be reorganization to some technical operations. The cuts will take place over the next two years and is expected to save the company about $2.4 billion.
Our sister publication GenomeWeb Daily News has more here.